ZLc002, a putative small molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability - UTU Tutkimustietojärjestelmä

A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

ZLc002, a putative small molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability

Tekijät: Lee Wan-Hung, Carey Lawrence, Li Li-Li, Xu Zhili, Lai Yvonne, Courtney Michael, Hohmann Andrea

Julkaisuvuosi: 2018

Journal: Molecular Pain

Vuosikerta: 14

Sivujen määrä: 17

ISSN: 1744-8069

DOI: https://doi.org/10.1177/1744806918801224

Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/33799251

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.

1744806918801224.pdf